Advisory Services Network, LLC Horizon Therapeutics Public LTD CO Transaction History

Advisory Services Network, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$62.39 - $113.8 $74,244 - $135,422	1,190 New	1,190 $135,000
Q3 2021 Nov 05, 2021	SELL	$91.91 - $110.37 $105,696 - $126,925	-1,150 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$86.24 - $95.92 $99,176 - $110,308	1,150 New	1,150 $108,000
Q1 2021 May 24, 2021	SELL	$71.83 - $95.48 $82,604 - $109,802	-1,150 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$67.0 - $84.39 $563,805 - $710,141	-8,415 Reduced 87.98%	1,150 $84,000
Q3 2020 Nov 16, 2020	BUY	$55.23 - $79.93 $528,274 - $764,530	9,565 New	9,565 $743,000
Q2 2020 Aug 10, 2020	SELL	$30.2 - $56.98 $35,907 - $67,749	-1,189 Closed	0 $0
Q4 2019 Feb 04, 2020	SELL	$25.43 - $36.67 $57,980 - $83,607	-2,280 Reduced 65.72%	1,189 $43,000
Q2 2019 Aug 01, 2019	BUY	$22.81 - $28.48 $72,535 - $90,566	3,180 Added 1100.35%	3,469 $0
Q1 2019 May 20, 2019	BUY	$19.49 - $29.01 $5,632 - $8,383	289 New	289 $8,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.